Cystatin C and its Role in the Neuro-Glial-Vascular Unit: Implications for Cerebrovascular Diseases and Neurodegeneration
- 12 October 2026
- journal article
- review article
- Published by Springer Nature in Neuroscience Bulletin
- p. 1-27
Abstract
Cystatin C (CysC) is emerging as a key regulator and intercellular signaling mediator within the neuro-glial-vascular unit (NGVU). This review comprehensively examines its multifaceted roles across NGVU components, detailing mechanisms by which CysC preserves blood–brain barrier integrity, modulates neuroinflammation, and influences pathological protein aggregation. Rather than providing a merely descriptive catalogue, we emphasize its context-dependent nature. In cerebrovascular and neurodegenerative diseases, CysC exhibits functional duality along the neuron–glia axis, either restraining or perpetuating inflammation and proteinopathy depending on cellular context and disease stage. Similarly, along the endothelial–oligodendrocyte precursor cell crosstalk, its coordination of angiogenesis and myelination may shift from protective to detrimental under chronic hypoperfusion. We evaluate its dual utility as a clinical biomarker and therapeutic target, addressing challenges in brain delivery, target selectivity, and safety. This integrative synthesis provides a critical perspective on unresolved controversies and future research priorities regarding CysC in neurological disorders.Keywords
This publication has 278 references indexed in Scilit:
- Associations of blood biomarkers of glial cell dysfunction and neuronal injury with future cognitive decline and incident dementiaAlzheimer's & Dementia, 2026
- Biomarkers, Cognitive Function, and Mortality in CentenariansJAMA Network Open, 2026
- Pathological Roles of Astrocytes in Traumatic Brain InjuryCNS Neuroscience & Therapeutics, 2026
- Plasma GFAP and NLRP3 Associate with Cognitive Impairment After Recent Small Subcortical Infarct via Periventricular White Matter HyperintensityCNS Neuroscience & Therapeutics, 2026
- Diagnostic accuracy of plasma p‐tau217/Aβ42 for Alzheimer's disease in clinical and community cohortsAlzheimer's & Dementia, 2025
- Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's DiseaseAdvanced Science, 2024
- A top‐down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controlsProteomics, 2023
- Coronary artery calcium and cystatin C for risk stratification of MACCEs and all‐cause death in symptomatic patientsClinical Cardiology, 2022
- Cystatin C as a marker of cognitive function in elders: Findings from the health ABC studyAnnals of Neurology, 2008
- Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer DiseaseArchives of Neurology, 2000